BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 23540551)

  • 1. Dysphagia and trismus after concomitant chemo-Intensity-Modulated Radiation Therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures.
    van der Molen L; Heemsbergen WD; de Jong R; van Rossum MA; Smeele LE; Rasch CR; Hilgers FJ
    Radiother Oncol; 2013 Mar; 106(3):364-9. PubMed ID: 23540551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of long term (10-years+) dysphagia and trismus in patients treated with concurrent chemo-radiotherapy for advanced head and neck cancer.
    Kraaijenga SA; Oskam IM; van der Molen L; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW
    Oral Oncol; 2015 Aug; 51(8):787-94. PubMed ID: 26027851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures.
    Feng FY; Kim HM; Lyden TH; Haxer MJ; Feng M; Worden FP; Chepeha DB; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1289-98. PubMed ID: 17560051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the Effect of Radiotherapy Dose on Chewing and Swallowing Structures in Head and Neck Cancer Patients Treated with Concomitant Chemoradiotherapy.
    Baştuğ Dumbak A; Esen Aydınlı F; Yazıcı G; İncebay Ö; Yıldız Z; Yüce D; Süslü N; Kuşçu O; Kulak Kayıkcı ME
    Dysphagia; 2022 Dec; 37(6):1400-1413. PubMed ID: 35075541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters.
    Mortensen HR; Jensen K; Aksglæde K; Behrens M; Grau C
    Radiother Oncol; 2013 Jun; 107(3):288-94. PubMed ID: 23791365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study.
    Christianen ME; Schilstra C; Beetz I; Muijs CT; Chouvalova O; Burlage FR; Doornaert P; Koken PW; Leemans CR; Rinkel RN; de Bruijn MJ; de Bock GH; Roodenburg JL; van der Laan BF; Slotman BJ; Verdonck-de Leeuw IM; Bijl HP; Langendijk JA
    Radiother Oncol; 2012 Oct; 105(1):107-14. PubMed ID: 21907437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation dose to dysphagia aspiration-related structures and its effect on swallowing: Comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy plans.
    Prameela CG; Ravind R; Renil Mon PS; Sheejamol VS; Dinesh M
    J Cancer Res Ther; 2016; 12(2):845-51. PubMed ID: 27461662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures.
    Dirix P; Abbeel S; Vanstraelen B; Hermans R; Nuyts S
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):385-92. PubMed ID: 19553033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trismus in patients with oropharyngeal cancer: relationship with dose in structures of mastication apparatus.
    Teguh DN; Levendag PC; Voet P; van der Est H; Noever I; de Kruijf W; van Rooij P; Schmitz PI; Heijmen BJ
    Head Neck; 2008 May; 30(5):622-30. PubMed ID: 18213726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
    van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA;
    Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation dose to the masseter and medial pterygoid muscle in relation to trismus after chemoradiotherapy for advanced head and neck cancer.
    Kraaijenga SA; Hamming-Vrieze O; Verheijen S; Lamers E; van der Molen L; Hilgers FJ; van den Brekel MW; Heemsbergen WD
    Head Neck; 2019 May; 41(5):1387-1394. PubMed ID: 30652390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-volume factors correlating with trismus following chemoradiation for head and neck cancer.
    Rao SD; Saleh ZH; Setton J; Tam M; McBride SM; Riaz N; Deasy JO; Lee NY
    Acta Oncol; 2016; 55(1):99-104. PubMed ID: 25920361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy.
    MD Anderson Head and Neck Cancer Symptom Working Group
    Radiother Oncol; 2016 Feb; 118(2):304-14. PubMed ID: 26897515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship.
    Levendag PC; Teguh DN; Voet P; van der Est H; Noever I; de Kruijf WJ; Kolkman-Deurloo IK; Prevost JB; Poll J; Schmitz PI; Heijmen BJ
    Radiother Oncol; 2007 Oct; 85(1):64-73. PubMed ID: 17714815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation-induced trismus in the ARTSCAN head and neck trial.
    Lindblom U; Gärskog O; Kjellén E; Laurell G; Levring Jäghagen E; Wahlberg P; Zackrisson B; Nilsson P
    Acta Oncol; 2014 May; 53(5):620-7. PubMed ID: 24669774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term quality of life after swallowing and salivary-sparing chemo-intensity modulated radiation therapy in survivors of human papillomavirus-related oropharyngeal cancer.
    Vainshtein JM; Moon DH; Feng FY; Chepeha DB; Eisbruch A; Stenmark MH
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):925-33. PubMed ID: 25832685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer.
    Bhide SA; Gulliford S; Kazi R; El-Hariry I; Newbold K; Harrington KJ; Nutting CM
    Radiother Oncol; 2009 Dec; 93(3):539-44. PubMed ID: 19883951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck.
    Caudell JJ; Schaner PE; Desmond RA; Meredith RF; Spencer SA; Bonner JA
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):403-9. PubMed ID: 19467801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical considerations in reducing swallowing dysfunction following concurrent chemoradiotherapy with intensity-modulated radiotherapy for head and neck cancer.
    Batth SS; Caudell JJ; Chen AM
    Head Neck; 2014 Feb; 36(2):291-8. PubMed ID: 23508721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-volume analysis of radiation-induced trismus in head and neck cancer patients.
    Gebre-Medhin M; Haghanegi M; Robért L; Kjellén E; Nilsson P
    Acta Oncol; 2016 Nov; 55(11):1313-1317. PubMed ID: 27595312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.